期刊文献+

恶性高热实验室诊断方法的初步建立 被引量:4

Preliminary establishment of the laboratory diagnostic test for malignant hyperthermia
原文传递
导出
摘要 目的初步建立恶性高热(MH)的实验室诊断方法-咖啡因-氟烷骨骼肌收缩试验(CHCT)。方法选取10头实验小型猪和1头皮特兰猪,肌肉注射氯胺酮和地西泮麻醉后,静脉注射硫喷妥钠5mg/kg和琥珀胆碱2mg/kg麻醉诱导后气管插管,机械通气,吸入2%-3%氟烷4h,新鲜气流量为2L/min,纯氧和空气各1L/min。记录麻醉过程中及麻醉结束后48h内MH的发生情况。气管插管后即刻取耳组织,采用常规酚氯仿方法提取基因组DNA,检测蓝尼定受体-1(RYR1)基因的突变情况。根据北美MH研究组的标准建立CHCT的实验装置,气管插管后即刻取股四头肌近肌腱部位的肌纤维,进行CHCT。结果实验小型猪均未见MH发作,而皮特兰猪在麻醉过程中出现MH的特征性表现。RYR1基因检测显示,实验小型猪均为氟烷抗性基因型(HALNN);皮特兰猪为氟烷易感基因型(HALnn)。CHCT结果表明,实验小型猪诊断为非MH易感猪,皮特兰猪诊断为MH易感猪。结论实验小型猪和皮特兰猪的CHCT诊断结果与特征性表现及RYR1基因检测结果均一致,初步验证本实验室CHCT设备的稳定性及测定结果的可靠性。 Objective To preliminarily establish laboratory diagnostic test for malignant hyperthermia (MH) -- caffeine and halothane contracture test (CHCT). Methods Ten Chinese experimental miniature pigs (CEMP) and one pietrain swine were selected in this study. The animals were anesthetized with ketamine and diazepam. Anesthesia was induced with thiopental sodium 5 mg/kg and tracheal intubation was facilitated with succinylcholine 2 mg/kg intravenously. The animals were mechanically ventilated and anesthesia was maintained with inhalation of 2 %-3 % halothane for 4 h. Frash gas flow was set at 2 L/min and oxygen and air flow at 1 L/ min. All the aninals were observed whether the MH episodes were initiated or not during the process of anesthesia and 48 h after anesthesia. Ear tissues were removed immediately after tracheal intubation and the genome DNA was extracted by classic SDS-proteinase K-hydroxybenzene-chloroforra method to detect mutations in the RYR1 gene. The laboratory devices of CHCT were established according to the North America MH Group protocol and muscle fibers of femoral quadriceps near tendon were taken to perform CHCT. Results Characteristic manifestations of MH were not found in the CEMPs during and after anesthesia but in the Pietrain swine during anesthesia. The RYR1 genotype of the CEMPs was HALNN and the Pietrain swine HALnn. The CEMPs were diagnosed as MH non-susceptibility and the Pietrain swine as MH susceptibility according to CHCT. Conclusion The CHCT results of CEMPs and Pietrain swine are consistent with those of characteristic manifestations and genetic detection, demonstrating that the devices of CHCT are overall steady-going and the results reliable;
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2008年第6期526-529,共4页 Chinese Journal of Anesthesiology
关键词 恶性高热 咖啡因 氟烷 肌收缩 骨骼 Malignant hyperthermia Caffeine Halothane Muscle contraction Muscle,skeletal
  • 相关文献

参考文献11

  • 1McCarthy EJ. Malignant hyperthermia: pathophysiology, clinical presentation,and treatment. AACN Clin Issues, 2004,15:231-237. 被引量:1
  • 2王颖林,郭向阳,罗爱伦.我国大陆恶性高热病例的分析[J].中华麻醉学杂志,2006,26(2):107-109. 被引量:45
  • 3Girard T, Treves S, Voronkov E, et al. Molecular genetic testing for malignant hyperthermia susceptibility. Anesthesiology, 2004,100: 1076- 1080. 被引量:1
  • 4王颖林,郭向阳,罗爱伦.恶性高热诊断和治疗的研究进展[J].中华麻醉学杂志,2006,26(1):92-94. 被引量:22
  • 5Schaefer AL. The use of blood serum components in the identification of stress-susceptibile and carcass pigs. Can J Anim Sci, 1990,70:845. 被引量:1
  • 6Dickson D. DNA testing helps British bring better pig to market. Nature, 1993,362 : 688. 被引量:1
  • 7Otsu K, Philips MS, Khanna VK, et al. Refinement of diagnostic assays for a probable causal mutation for porcine and human malignant hyperthermia. Genomics, 1992,13: 835-837. 被引量:1
  • 8Letcher JE, Conti PA, Rosenberg H. Comparison of North American and European malignant hyperthermia group halothane contracture testing protocols in swine. Acta Anaesthesiol Scand, 1991,35 : 483-487. 被引量:1
  • 9Larach MG. Standardization of the caffeine halothane muscle contracture test, North American Malignant Hyperthermia Group. Anesth Analg, 1989,69:511-515. 被引量:1
  • 10Fujii J, Otsu K, Zorzato F,et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science, 1991,253 : 448-451. 被引量:1

二级参考文献43

  • 1孔琴,周期.儿童术后恶性高热二例报告[J].海南医学,2001,12(9):95-96. 被引量:1
  • 2张伯勋,卢世璧.恶性高热的术前预测及其防治[J].中华外科杂志,1993,31(5):298-300. 被引量:2
  • 3唐瞻贵,王永贵,郭新程,顾湘.唇裂全麻术后恶性高热的诊断与治疗[J].华西口腔医学杂志,1996,14(1):41-44. 被引量:6
  • 4Harrison G.Dosage of dantrolene:"empiric"please! Anaesth Intensive Care,2003,31:122. 被引量:1
  • 5McCarthy EJ.Malignant hyperthermia:pathophysiology,clinical presentation,and treatment.AACN Clin Issues,2004,15:231-237. 被引量:1
  • 6Larach MG,Localio AR,Allen GC,et al.A clinical grading scale to predict malignant hyperthermia susceptibility.Anesthesiology,1994,80:771-779. 被引量:1
  • 7Hopkins PM.Malignant hyperthermia:advances in clinical management and diagnosis.Br J Anaesth,2000,85:118-128. 被引量:1
  • 8Islander G,Twetman ER.Comparison between the European and North American protocols for diagnosis of malignant hyperthermia susceptibility in humans.Anesth Analg,1999,88:1155-1160. 被引量:1
  • 9Bendahan D,Guis S,Monnier N,et al.Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine:a comparative investigation in malignant hyperthermia.Acta Anaesthesiol Scand,2004,8:1019-1027. 被引量:1
  • 10Bendahan D,Kozak Ribbens G,Rodet L,et al.31 Phosphorus magnetic resonance spectroscopy characterization of musclular metabolic anomalies in patients with malignant hyperthermia:application to diagnosis.Anesthesiology,1998,88:96-107. 被引量:1

共引文献56

同被引文献52

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部